The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Items 601–791 of 791
Misra, P., Qi, C., Yu, S., Shah, S. H., Cao, W.-Q., Rao, M. S., Thimmapaya, B., Zhu, Y., & Reddy, J. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201739200 · Cited by 75
Kim, R. H., Flanders, K. C., Reffey, S. B., Anderson, L. A., Duckett, C. S., Perkins, N. D., & Roberts, A. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103819200 · Cited by 75
Glucocorticoid-Induced Apoptosis and Regulation of NF-κB Activity in Human Leukemic T Cells*
Ramdas, J., & Harmon, J. M. (1998) · Endocrinology · doi:10.1210/endo.139.9.6180 · Cited by 74 · cited 1×
“Interestingly, I B- induction was found in GC-induced apoptosis-sensitive cells, but not in resistant human leukemic T cells (335).”
BackgroundLukiw, W. J., Peláez, R. P., Martínez, J., & Bazan, N. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3914 · Cited by 74
Haddad, J. J., Saadé, N. E., & Safieh‐Garabedian, B. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00075-x · Cited by 74
Protein dynamics in the nuclear compartment
Hager, G. L., Elbi, C., & Becker, M. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00278-2 · Cited by 74
Tang, Y., Getzenberg, R. H., Vietmeier, B. N., Stallcup, M. R., Eggert, M., Renkawitz, R., & DeFranco, D. B. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.9.0169 · Cited by 73
Zaman, Z., Ansari, A. Z., Koh, S. S., Young, R., & Ptashne, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041611198 · Cited by 73
Espinosa, L., Santos, S., Inglés‐Esteve, J., Muñoz‐Cánoves, P., & Bigas, A. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1295 · Cited by 72
Planey, S. L., Abrams, M. T., Robertson, N. M., & Litwack, G. (2003) · PubMed · Cited by 71
DNA-Dependent Protein Kinase Phosphorylation of IκBα and IκBβ Regulates NF-κB DNA Binding Properties
Liu, L., Kwak, Y.-T., Bex, F., García-Martínez, L. F., Li, X.-H., Meek, K., Lane, W. S., & Gaynor, R. B. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4221 · Cited by 71
BAG-1 family of cochaperones in the modulation of nuclear receptor action
Cato, A. C. B., & Mink, S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00114-5 · Cited by 71 · cited 1×
“tors in the nucleus (108) by dynamic (dis)assembly of various”
BackgroundTAF II mutations disrupt Dorsal activation in the Drosophila embryo
Zhou, J., Zwicker, J., Szymanski, P., Levine, M., & Tjian, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13483 · Cited by 71
Hormone activation induces nucleosome positioning in vivo
Belikov, S. V., Gelius, B., Almouzni, G., & Wränge, Ö. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.1023 · Cited by 71
Zilliacus, J. (2001) · Molecular Endocrinology · doi:10.1210/me.15.4.501 · Cited by 71
Dean, D. A., Urban, G., Aragon, I. V., Swingle, M. R., Miller, B. A., Rusconi, S., Bueno, M., Dean, N. M., & Honkanen, R. E. (2001) · BMC Cell Biology · doi:10.1186/1471-2121-2-6 · Cited by 71
Suh, J., Jeon, Y. J., Kim, H. M., Kang, J. S., Kaminski, N. E., & Yang, K. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9403 · Cited by 70
Phosphorylation of steroid hormone receptors
Orti, E. (1992) · Endocrine Reviews · doi:10.1210/er.13.1.105 · Cited by 70
Drouin, J., Maira, M., & Philips, A. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00180-5 · Cited by 69
Glucocorticoid Receptor Activation of the IκBα Promoter within Chromatin
Deroo, B. J., & Archer, T. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.11.3365 · Cited by 69 · cited 2×
“On the other hand, when investigating the chromatin structure of the I B- promoter on GC treatment, GCs did not affect the global nucleosome positioning, but rather allosterically interfered with DNA binding of transcription factors (259, 586).”
BackgroundHsia, S.-C. V., & Shi, Y.-B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4043-4052.2002 · Cited by 69 · cited 1×
“Exposure of the HIV-long terminal repeat (LTR) to hormones was found to result in disruption of the nucleosomal array within the NF- B/Sp1 promoter region (585).”
BackgroundStevens, A., Garside, H., Berry, A. A., Waters, C. E., White, A. E., & Ray, D. W. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0320 · Cited by 68
Ting, A. Y., & Endy, D. (2002) · Science · doi:10.1126/science.1079331 · Cited by 67
Hauk, P. J., Goleva, E., Strickland, I., Vottero, A., Chrousos, G. P., Kisich, K. O., & Leung, D. Y. M. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.4861 · Cited by 66
A role for endogenous glucocorticoids in wound repair
Grose, R., Werner, S., Kessler, D., Tuckermann, J., Huggel, K., Durka, S., Reichardt, H. M., & Werner, S. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf119 · Cited by 66 · cited 1×
“Furthermore, GCs affect organ development, tissue maturation, wound healing, and calcium reabsorption (104, 119).”
BackgroundHolloway, A. F., Rao, S., Chen, X., & Shannon, M. F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021039 · Cited by 66
Falvo, J. V., Brinkman, B. M. N., Tsytsykova, A. V., Tsai, E. Y., Yao, T., Kung, A. L., & Goldfeld, A. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3925 · Cited by 66
Neckers, L. (2002) · PubMed · Cited by 65
Wallberg, A. E., Neely, K. E., Gustafsson, J.-Α., Workman, J. L., Wright, A. P. H., & Grant, P. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5952 · Cited by 65
Kuvibidila, S. R., Kitchens, D., & Baliga, B. S. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990901)74:3<468::aid-jcb14>3.0.co;2-g · Cited by 64
Inducible NF-κB Activation Is Permitted by Simultaneous Degradation of Nuclear IκBα
Renard, P., Percherancier, Y., Kroll, M., Thomas, D., Virelizier, J., Arenzana‐Seisdedos, F., & Bachelerie, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15193 · Cited by 63 · cited 1×
“Sustained NF- B/DNA binding and resynthesis of I B may coexist if resynthesized I B is simultaneously degraded (272).”
BackgroundA Necessary Good: Nuclear Hormone Receptors and Their Chromatin Templates
Urnov, F. D. (2001) · Molecular Endocrinology · doi:10.1210/me.15.1.1 · Cited by 62 · cited 1×
“It is quite likely (although demonstrations in vivo are currently lacking) that such remodeling effected by liganded NRs occurs by recruitment of large ATP-using complexes (563).”
BackgroundRegulation of the mRNA expression for tumor necrosis factor-α in rat liver macrophages
Grewe, M., Gausling, R., Gyufko, K., Hoffmann, R., & Decker, K. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80154-0 · Cited by 61
Chiba, N., Suldan, Z., Freedman, L. P., & Parvin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10719 · Cited by 61 · cited 1×
“Another way for GR-mediated repression might be the targeting of non-HAT-containing cofactors, bridging p65 or AP-1 activation domains to the RNA polymerase holoenzyme (240, 589) (Fig.”
BackgroundMechanisms of Glucocorticoid‐Resistant Asthmaa
LEUNG, D. Y. M., de CASTRO, M., SZEFLER, S. J., & CHROUSOS, G. P. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09612.x · Cited by 61 · cited 1×
“A small proportion of asthmatic patients are GC-resistant and fail to respond to even high doses of oral steroids; other chronic inflammatory diseases, such as inflammatory bowel disease, rheumatoid arthritis, and Crohn’s disease, display similar incidences of impaired responsiveness (700, 701).”
BackgroundEmerging immune targets for the therapy of allergic asthma
Corry, D. B. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd702 · Cited by 61
Uz, T., Dwivedi, Y., Savani, P. D., Impagnatiello, F., Pandey, G. N., & Manev, H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730693.x · Cited by 61
Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response
Webster, J. I., & Carlstedt‐Duke, J. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00227-3 · Cited by 60 · cited 1×
“NR mutations affecting ligand binding or cofactor affinities, changed cofactor expression levels, NF- B-dependent expression of the multidrug resistance protein MDR1, oncogenic activation of growth factorsignaling pathways, and altered circuitry in nongenomic NR pathways (549, 720, 721).”
BackgroundAntiinflammatory Effects of Glucocorticoids in Brain Cells, Independent of NF-κB
Bourke, E., & Moynagh, P. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2113 · Cited by 60
Hofmann, T. G., Hehner, S. P., Bacher, S., Dröge, W., & Schmitz, M. L. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01609-3 · Cited by 59 · cited 1×
“Along the same line, a study comparing the activity of various clinically important GCs showed that it is possible to prevent TNF-induced degradation of I B- to various extents without affecting the NF- B/DNA-binding activity (324).”
BackgroundKino, T., & Chrousos, G. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209234200 · Cited by 59
Gilbert, R. S., & Herschman, H. R. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570117 · Cited by 58
Widén, C., Zilliacus, J., Gustafsson, J.-Α., & Wikström, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006943200 · Cited by 58
INTERLEUKIN-10 STABILIZES INHIBITORY kB-α IN HUMAN MONOCYTES
Shames, B. D., Selzman, C. H., Meldrum, D. R., Pulido, E. J., Barton, H. A., Meng, X., Harken, A. H., & Mclntyre, R. C. (1998) · Shock · doi:10.1097/00024382-199812000-00002 · Cited by 58
Ron, D., Brasier, A. R., Wright, K. A., & Habener, J. F. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.4389-4395.1990 · Cited by 58
Glucocorticoid-induced osteoporosis: pathogenesis and management
Nishimura, J., & Ikuyama, S. (2000) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740070008 · Cited by 57
Hormone-mediated Dephosphorylation of Specific Histone H1 Isoforms
Banks, G. C., Deterding, L. J., Tomer, K. B., & Archer, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104641200 · Cited by 57 · cited 1×
“Several reports have already focused on the association of GR with components of the BRG-1 and/or SWI/SNF complex and showed that GR can alter chromatin-remodeling properties (564–570); recruitment was demonstrated to depend on surrounding histone H1 phosphorylation (506, 571, 572) and to require the transactivation d…”
BackgroundFifty Years of Experience with Cortisone Therapy in the Study and Treatment of Rheumatoid Arthritis
Neeck, G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04199.x · Cited by 57 · cited 1×
“To that end, many investigators are currently trying to elucidate how GCs exert their mechanism of action (177, 199).”
BackgroundA NF-κB/c- myc -Dependent Survival Pathway Is Targeted by Corticosteroids in Immature Thymocytes
Wang, W., Wykrzykowska, J. J., Johnson, T., Sen, R., & Sen, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.314 · Cited by 57 · cited 1×
“Alternatively, in T cells, stimulation of I B- in response to GCs could have evolved to counter the antiapoptotic effects of constitutive NF- B levels by reducing its DNA binding (331).”
BackgroundNUREBASE: database of nuclear hormone receptors
Duarte, J., Perrière, G., Laudet, V., & Robinson‐Rechavi, M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.364 · Cited by 57
Transcriptional and post‐transcriptional mechanisms of glucocorticoid antiproliferative effects
Almawi, W. Y., Abou Jaoude, M. M., & Li, X. C. (2002) · Hematological Oncology · doi:10.1002/hon.684 · Cited by 56
Li, X. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1482 · Cited by 56 · cited 1×
“The key question to be addressed is whether a distinct GR cofactor configuration is involved in repression of NF- B-mediated gene expression (361, 362, 443, 461).”
BackgroundDissociative Glucocorticoid Activity of Medroxyprogesterone Acetate in Normal Human Lymphocytes
Bamberger, C. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4055 · Cited by 56
A Nonsteroidal Glucocorticoid Receptor Antagonist
Miner, J. N., Tyree, C., Hu, J., Berger, E., Marschke, K., Nakane, M., Coghlan, M. J., Clemm, D., Lane, B., & Rosen, J. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0010 · Cited by 55
Brewer, J. A., Sleckman, B. P., Swat, W., & Muglia, L. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1309 · Cited by 55
Hormone‐induced nucleosome positioning in the MMTV promoter is reversible
Belikov, S. V., Gelius, B., & Wrange, Ö. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2802 · Cited by 54
Teyssier, C., Belguise, K., Galtier, F., Cavaillès, V., & Chalbos, D. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0324 · Cited by 54 · cited 1×
“As such, it has been suggested that the ratio between the cofactors RIP140 (receptor-interacting protein 140) and GRIP1 (glucocorticoid receptor-interacting protein 1) codetermines a negative or positive transcriptional outcome on an AP-1-driven and estrogen-costimulated promoter (516).”
BackgroundRosen, T., Krikun, G., Ma, Y., Wang, E.-Y., Lockwood, C. J., & Guller, S. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5151 · Cited by 54
Trans-tail histone modifications: wedge or bridge?
Henry, K. W., & Berger, S. L. (2002) · Nature Structural Biology · doi:10.1038/nsb0802-565 · Cited by 53
Lin, C. W., Nakane, M., Stashko, M., Falls, D. H., Kuk, J. E., Miller, L. N., Huang, R., Tyree, C. M., Miner, J. N., Rosen, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.297 · Cited by 53
Gametchu, B., Watson, C. S., & Pasko, D. (1991) · Steroids · doi:10.1016/0039-128x(91)90028-t · Cited by 53
Chandra, J., Gilbreath, J., Freireich, E. J., Kliche, K. O., Andreeff, M., Keating, M. J., & McConkey, D. J. (1997) · Blood · doi:10.1182/blood.v90.9.3673 · Cited by 52
Kaul, S. C., Blackford, J. A., Chen, J., Ogryzko, V. V., & Simons, S. S. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.7.0494 · Cited by 51
Li, Q., Su, A., Chen, J., Lefebvre, Y. A., & Haché, R. J. G. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0154 · Cited by 50
Watson, C. S., & Gametchu, B. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00036-4 · Cited by 50
Antiinflammatory effects of glucocorticoids in brain cells, independent of NF-kappa B.
Bourke, E., & Moynagh, P. N. (1999) · PubMed · Cited by 49
Pei, L. (1996) · Journal of Biological Chemistry · doi:10.1074/s0021-9258(19)73912-x · Cited by 49
González, M. V., González‐Sancho, J. M., Caelles, C., Múñoz, A., & Jiménez, B. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01257-0 · Cited by 49
Quinkler, M., Oelkers, W., & Diederich, S. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440087 · Cited by 49
Allosteric Effects of Dexamethasone and RU486 on Glucocorticoid Receptor-DNA Interactions
Pandit, S., Geissler, W. M., Harris, G., & Sitlani, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105438200 · Cited by 49 · cited 1×
“Importantly, at a fixed DNA concentration, DEXbound GR dissociates from DNA 10 times faster than does ligand-free GR or RU486-bound GR (368).”
BackgroundA NF-kappa B/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes.
Wang, W., Wykrzykowska, J. J., Johnson, T., et al. (1999) · PubMed · Cited by 48
Huang, S.-T. J., & Cidlowski, J. A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0852com · Cited by 48 · cited 1×
“have been demonstrated to be critical players (126, 629).”
BackgroundGarrel, D. R. (2008) · Hormone Research · doi:10.1159/000184796 · Cited by 48 · cited 4×
“CBG homeostasis is normally restored after 1 or 2 d (132, 133).”
BackgroundInfluentialMultimeric Coactivator Complexes for Steroid/Nuclear Receptors
Freedman, L. P. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00208-8 · Cited by 48 · cited 1×
“specific subset of cofactors (261, 262) that may allow the GR to cooperate, perhaps even in a DNA-binding independent way, with other LPS- or TNF-activated transcription factors in the I B- -promoter.”
BackgroundExploring the transcription–chromatin interface: Figure 1.Preprint
Jones, K. A., & Kadonaga, J. T. (2000) · Genes & Development · doi:10.1101/gad.14.16.1992 · Cited by 48
SEGRAs: A Novel Class of Anti-inflammatory Compounds
Schäcke, H., Hennekes, H., Schottelius, A. J. G., Jaroch, S., Lehmann, M., Schmees, N., Rehwinkel, H., & Asadullah, K. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_20 · Cited by 47
Studies on the arrangement of glucocorticoid receptors in the plasma membrane of S-49 lymphoma cells
Gametchu, B., Watson, C. S., Shih, C. C.-Y., & Dashew, B. (1991) · Steroids · doi:10.1016/0039-128x(91)90029-u · Cited by 47
Algarté-Génin, M., Kwon, H., Génin, P., & Hiscott, J. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6140 · Cited by 47 · cited 1×
“On the other hand, when investigating the chromatin structure of the I B- promoter on GC treatment, GCs did not affect the global nucleosome positioning, but rather allosterically interfered with DNA binding of transcription factors (259, 586).”
BackgroundAlteration of the glucocorticoid receptor subcellular localization by non steroidal compounds
Prima, V., Depoix, C. L., Masselot, B., Formstecher, P., & Lefèbvre, P. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00146-6 · Cited by 47
Inhibition of heat shock transcription factor by GR.
Wadekar, S., Li, D.-P., Periyasamy, S., & Sánchez, E. R. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.8.0674 · Cited by 46
Unlap, M. T., & Jope, R. S. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00240-9 · Cited by 46 · cited 1×
“It would be interesting to investigate the underlying basis and the reason for the variations observed between related cell types in the same animal (273, 274).”
BackgroundInteraction of steroid hormone receptors with transcription factors involves chromatin remodelling
Beato, M., Candau, R., Chávez, S., Möws, C. C., & Truss, M. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00223-5 · Cited by 45
Temporal Formation of Distinct Thyroid Hormone Receptor Coactivator Complexes in HeLa Cells
Sharma, D., & Fondell, J. D. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.12.0567 · Cited by 44
Bendrups, A., Hilton, A., Meager, A., & Hamilton, J. A. (1992) · Rheumatology International · doi:10.1007/bf00301004 · Cited by 44
Sendo, F., Tsuchida, H., Takeda, Y., Gon, S., Takei, H., Kato, T., Hachiya, O., & Watanabe, H. (1996) · PubMed · Cited by 44
Stauber, C., Altschmied, J., Akerblom, I. E., Marrón, J., & Mellon, P. L. (1992) · PubMed · Cited by 43
Kucera, T., Waltner-Law, M., Scott, D. K., Prasad, R., & Granner, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204013200 · Cited by 42
Ray, A., LaForge, K. S., & Sehgal, P. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7086 · Cited by 42
Brasier, A. R., Ron, D., Tate, J. E., & Habener, J. F. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1921 · Cited by 42
Multiplicity of Glucocorticoid Action in Inhibiting Allograft Rejection
Almawi, W. Y., Hess, D. A., & Rieder, M. J. (1998) · Cell Transplantation · doi:10.1016/s0963-6897(98)00042-6 · Cited by 42
c-Jun Binds the N Terminus of Human TAFII250 to Derepress RNA Polymerase II Transcription in Vitro
Lively, T. N., Ferguson, H. A., Galasinski, S. K., Seto, A. G., & Goodrich, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100278200 · Cited by 42
Oren, A., Herschkovitz, A., Ben‐Dror, I., Holdengreber, V., Ben‐Shaul, Y., Seger, R., & Vardimon, L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1742 · Cited by 42 · cited 1×
“on promoter, receptor, and cell type (248, 249).”
BackgroundYen, P. M., Liu, Y., Palvimo, J. J., Trifiro, M. A., Whang, J., Pinsky, L., Jänne, O. A., & Chin, W. W. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.2.9886 · Cited by 41
Paal, K., Baeuerle, P. A., & Schmitz, M. L. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.5.1050 · Cited by 41
Gene Regulation Associated with Apoptosis
Jehn, B. M., & Osborne, B. A. (1997) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v7.i1-2.100 · Cited by 41
Wan, Y., Coxe, K. K., Thackray, V. G., Housley, P. R., & Nordeen, S. K. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.1.0584 · Cited by 41
Glucocorticoid use in rheumatoid arthritis
Saag, K. G. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0068-z · Cited by 41
Cakouros, D., Cockerill, P. N., Bert, A. G., Mital, R., Roberts, D., & Shannon, M. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.302 · Cited by 40
SUBRAMANIAM, N., CAIRNS, W., & OKRET, S. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.153 · Cited by 40 · cited 1×
“Finally, a nGRE/Pit1/ XTF composite element was detected in the PRL3 gene (223).”
BackgroundGarcia-Gras, E. A., Chi, P., & Thompson, E. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001048200 · Cited by 40
Evans, S. J., Moore, F. L., & Murray, T. F. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00070-3 · Cited by 40
Hsp70–RAP46 interaction in downregulation of DNA binding by glucocorticoid receptor
Schneikert, J., Hübner, S., Langer, G., Petri, T., Jäättelä, M., Reed, J., & Cato, A. C. B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6508 · Cited by 40 · cited 1×
“Other levels of regulation that determine GC sensitivity include variations in the receptor protein (mutations, polymorphisms, isoforms) (141– 147), alternative receptor dimerization (GR heterodimerization has been described with MR, PR, and AR) (144, 148–151), presence of GC modulatory element binding proteins (152–…”
BackgroundDevelopment of peptide antagonists that target estrogen receptor–cofactor interactions
McDonnell, D. P., Chang, C., & Norris, J. D. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00109-6 · Cited by 39
Robin-Jagerschmidt, C., Wurtz, J., Guillot, B., Gofflo, D., Benhamou, B., Vergezac, A., Ossart, C., Moras, D., & Philibert, D. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.7.0484 · Cited by 38
Physical association between the histone acetyl transferase CBP and a histone methyl transferase
Vandel, L., & Trouche, D. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve002 · Cited by 38
Glucocorticoids in Rheumatoid Arthritis: Effects on Erosions and Bone
Bijlsma, J. W. J., van Everdingen, A. A., Huisman, M., NIJS, R. N. J. T. L. D., & Jacobs, J. W. G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04205.x · Cited by 38
Lambert, J. R., & Nordeen, S. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32708 · Cited by 37 · cited 1×
“As such, chromatin remodeling effects induced by GR can vary according to the chromosomal location (381, 582).”
BackgroundSaura, M., Zaragoza, C., Dı́az-Cazorla, M., Hernández‐Perera, O., Eng, E., Lowenstein, C. J., Pérez‐Sala, D., & Lamas, S. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00725.x · Cited by 36 · cited 1×
“The need for induction of I B- could, for instance, provide a molecular explanation for the limited efficacy of GCs in the therapy of septic shock (327).”
Background5-Lipoxygenase Upregulation by Dexamethasone in Human Mast Cells
Colamorea, T., Paola, R. D., Macchia, F., Guerrese, M.-C., Tursi, A., Butterfield, J. H., Caiaffa, M. F., Haeggström, J. Z., & Macchia, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1732 · Cited by 36
Mehindate, K., Al‐Daccak, R., Schall, T. J., & Mourad, W. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31601-6 · Cited by 35
Transcription factors AP-1 and NF-κB: Where steroids meet the gold standard of anti-rheumatic drugs
Handel, M. L. (1997) · Inflammation Research · doi:10.1007/s000110050188 · Cited by 35
He, Y., Szapary, D., & Simons, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205536200 · Cited by 35
Protein regulation: Tag wrestling with relatives of ubiquitin
Hodges, M., Tissot, C., & Freemont, P. S. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00477-0 · Cited by 35 · cited 2×
“(73, 74) as well as for GR (167, 170, 171).”
Xie, H., Seward, R., & Huber, B. T. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00128-4 · Cited by 33
Hu, J.-M., Bodwell, J. E., & Munck, A. U. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.3.9896 · Cited by 32
Shah, O. J., Iñiguez-Lluhí, J. A., Romanelli, A., Kimball, S. R., & Jefferson, L. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105935200 · Cited by 32
The role of chromatin in transcriptional regulation
Li, Q., Wränge, Ö., & Eriksson, P. O. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00016-2 · Cited by 32
Hofmann, T. G., & Schmitz, M. L. (2002) · Biological Chemistry · doi:10.1515/bc.2002.219 · Cited by 30
Hypothalamic-Pituitary-Adrenal Axis in Corticosteroid-Resistant Bronchial Asthma
Lane, S. M., Atkinson, B., Swaminathan, R., & Lee, T. H. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564097 · Cited by 30 · cited 1×
“This may explain why patients with GC-resistant asthma are not resistant to the endocrine and metabolic effects of GCs and thus develop GC side effects (702).”
BackgroundSheldon, L. A., Smith, C. L., Bodwell, J. E., Munck, A. U., & Hager, G. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8146 · Cited by 30
Temporal/spatial expression of nuclear receptor coactivators in the mouse lung
Naltner, A., Wert, S. E., Whitsett, J. A., & Yan, C. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1066 · Cited by 30
Necela, B. M., & Cidlowski, J. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00046-9 · Cited by 29 · cited 1×
“It would be an improvement for many steroid-treated patients if one could redesign GR function and reduce its side-effects while retaining the antiinflammatory characteristics (198).”
BackgroundIdentification of Protein Contact Sites within the Glucocorticoid/Progestin Response Element
Cairns, C. A., Gustafsson, J.-Α., & Carlstedt‐Duke, J. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-4-598 · Cited by 29
Wallberg, A. E., Flinn, E. M., Gustafsson, J.-Å., & Wright, A. P. H. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280410 · Cited by 29
Kinyamu, H. K., Fryer, C. J., Horwitz, K. B., & Archer, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001142200 · Cited by 29
Nuclear Matrix Targeting of Steroid Receptors: Specific Signal Sequences and Acceptor Proteins
DeFranco, D. B., & Guerrero, J. (2000) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v10.i1.60 · Cited by 28
Vicent, G. P., Pecci, A., Ghini, A. A., Piwien‐Pilipuk, G., & Galigniana, M. D. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5532 · Cited by 27 · cited 1×
“DEX is about 5 min) to result in biological effects (655, 656).”
BackgroundSteroid Responsiveness of Renal Epithelial Cells
de Haij, S., Adcock, I. M., Bakker, A. C., Gobin, S. J. P., Daha, M. R., & van Kooten, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209836200 · Cited by 27 · cited 1×
“GC-responsive tissues with an activated inflammatory response (mediated by activated NF- B) may become resistant to GC signaling because of a blocked GR function (180, 185, 698, 699).”
BackgroundAltering the Th1/Th2 balance as a therapeutic strategy in asthmatic diseases.
Ray, A., & Cohn, L. E. (2000) · PubMed · Cited by 27
Keeton, E. K., Fletcher, T. M., Baumann, C. T., Hager, G. L., & Smith, C. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203898200 · Cited by 26 · cited 1×
“chromatin-organized promoter templates, involvement of distinct GR domains was observed, depending on the chromatin status of the promoter (400).”
BackgroundFlick, M. B., Sapi, E., & Kacinski, B. M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10102.abs · Cited by 26
White, D. W., & Td, G. (1996) · PubMed · Cited by 26
Redox Regulation of the Glucocorticoid Receptor
Tanaka, H., Makino, Y., Okamoto, K., Iida, T., Yan, K., & Yoshikawa, N. (1999) · Antioxidants and Redox Signaling · doi:10.1089/ars.1999.1.4-403 · Cited by 25
NALDA, A. M., MARTIAL, J. A., & Müller, M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00176-7 · Cited by 25
Zeng, H., Plisov, S. Y., & Simons, S. S. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00208-7 · Cited by 25
Kato, M., & Schleimer, R. P. (1994) · Lung · doi:10.1007/bf00185082 · Cited by 25
A Steroid Response Element Can Function in the Absence of a Distal Promoter
Bradshaw, M. S., Tsai, M., & O’Malley, B. W. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1286 · Cited by 24
Shao, W., Rosenauer, A., Mann, K. K., Chang, C.-P. B., Rachez, C., Freedman, L. P., & Miller, W. H. (2000) · Blood · doi:10.1182/blood.v96.6.2233 · Cited by 23
Molecular Dynamics Studies of a Molecular Switch in the Glucocorticoid Receptor
Stockner, T., Sterk, H., Kaptein, R., & Bonvin, A. M. J. J. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00316-4 · Cited by 23 · cited 1×
“active and a transcriptionally inactive state (454).”
Deroo, B. J., & Archer, T. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00072-9 · Cited by 23 · cited 1×
“At least one cofactor complex, the BRG-1 chromatin remodeling complex, is thought to contribute to this differential promoter activation (588).”
BackgroundMultiplicity of Glucocorticoid Action in Inhibiting Allograft Rejection
Almawi, W. Y., Hess, D. A., & Rieder, M. J. (1998) · Cell Transplantation · doi:10.1177/096368979800700602 · Cited by 23
Preparing the target for the bullet
Muegge, K. (2002) · Nature Immunology · doi:10.1038/ni0102-16 · Cited by 22
Ventura, J., Roncero, C., Fabregat, I., & Benito, M. (1999) · Hepatology · doi:10.1002/hep.510290339 · Cited by 22
The antiproliferative effect of glucocorticoids: is it related to induction of TGF-beta?
Almawi, W. Y., & Irani-Hakime, N. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.10.2450 · Cited by 22
Stewart, S., & Crabtree, G. R. (2000) · Nature · doi:10.1038/35040690 · Cited by 22
Leo, C. P., Hsu, S. Y., & Hsueh, A. J. W. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0467 · Cited by 22
Pineda‐Molina, E., & Lamas, S. (2001) · BioFactors · doi:10.1002/biof.5520150213 · Cited by 21
Selective effects of 8-Br-cAMP on agonists and antagonists of the glucocorticoid receptor
Zhang, S., & Danielsen, M. (1995) · Endocrine · doi:10.1007/bf02917442 · Cited by 21
Heterogeneity of AtT-20 Cell Glucocorticoid Binding Sites: Evidence for a Membrane Receptor
Harrison, R. W., Balasubramanian, K., Yeakley, J. M., Fant, M. E., Švec, F., & Fairfield, S. J. (1979) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-6589-2_23 · Cited by 20
Steroid Receptor and Molecular Chaperone Encounters in the Nucleus
DeFranco, D. B., & Csermely, P. (2000) · Science Signaling · doi:10.1126/stke.2000.42.pe1 · Cited by 20
Corticosteroids and cardioprotection
Thiemermann, C. (2002) · Nature Medicine · doi:10.1038/nm0502-453 · Cited by 19
Induction and Repression of NF-κB-Driven Inflammatory Genes
Berghe, W. V., Bosscher, K. D., Vermeulen, L., Wilde, G., & Haegeman, G. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_14 · Cited by 18 · cited 2×
“Because no nGRE could be detected in the majority of inflammatory genes, transcriptional interference was discovered to mostly result from cross-talk between the GR and other transcription factors, such as NF- B or AP-1 (Table 2) (224, 225).”
BackgroundSelf-citationDichotomy of glucocorticoid action in the immune system
Asadullah, K., Schäcke, H., & Cato, A. C. B. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02147-0 · Cited by 18
A complex containing βTrCP recruits Ccd34 to catalyse ubiquitination of IκBα
Vuillard, L. M., Nicholson, J., & Hay, R. T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00895-9 · Cited by 18
Handel, M. L., Nguyen, L. Q., & Lehmann, T. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03216.x · Cited by 18
Structure/Activity Elements of the Multifunctional Protein, GMEB-1
Chen, J., Kaul, S. C., & Simons, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202311200 · Cited by 17
Corticosteroid-induced osteoporosis: pathogenesis and prevention.
Benvenuti, S., & Brandi, M. L. (2000) · PubMed · Cited by 16
Molecular mechanisms of glucocorticoid resistance
Bantel, H., Domschke, W., & Schulze‐Osthoff, K. (2000) · Gastroenterology · doi:10.1053/gast.2000.19224 · Cited by 16 · cited 1×
“A small proportion of asthmatic patients are GC-resistant and fail to respond to even high doses of oral steroids; other chronic inflammatory diseases, such as inflammatory bowel disease, rheumatoid arthritis, and Crohn’s disease, display similar incidences of impaired responsiveness (700, 701).”
BackgroundHow Chromatin Changes Its Shape
Hagmann, M. (1999) · Science · doi:10.1126/science.285.5431.1200 · Cited by 15
Corticosteroids in Ophthalmology
Pleyer, U., & Sherif, Z. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_5 · Cited by 14
Topical Glucocorticoid Therapy in Dermatology
Sterry, W., & Asadullah, K. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_3 · Cited by 13
Glucocorticoid inhibition of cytokine-induced E-selectin promoter activation
Ray, K. P., & SEARLE, N. (1997) · Biochemical Society Transactions · doi:10.1042/bst025189s · Cited by 13
Switching Partners in a Regulatory Tango
Nishioka, K., & Reinberg, D. (2001) · Science · doi:10.1126/science.1067622 · Cited by 12
Glucocorticoid Receptor Antagonism of AP-1 Activity by Inhibition of MAPK Family
Caelles, C., Bruna, A., Morales, M., González‐Sancho, J. M., González, M. V., Jiménez, B., & Múñoz, A. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_9 · Cited by 11
Do glucocorticoids enhance eosinopoiesis?
Elsas, M., Vargaftig, B. B., & Xavier‐Elsas, P. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01568-6 · Cited by 11 · cited 1×
“pathways, effects on cytokine receptor expression (120, 121), regulation of thymocyte and lymphocyte survival, selection, and functions (122–126), as well as interference with eosinopoiesis (127) or erythropoiesis (128).”
BackgroundThe tail does not always wag the dog
Luger, K. (2002) · Nature Genetics · doi:10.1038/ng1000 · Cited by 11
Role of the composite glucocorticoid response element in proliferin gene expression.
Ma, H., Mordacq, J. C., & Di, L. (1995) · Europe PMC (PubMed Central) · Cited by 11
Functional Implications of Glucocorticoid Receptor Trafficking
DeFranco, D. B. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_7 · Cited by 10
Analysis of Glucocorticoid Receptor Function in the Mouse by Gene Targeting
Kellendonk, C., Tronche, F., Reichardt, H. M., Bauer, A., Greiner, E. F., Schmid, W., & Schütz, G. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_17 · Cited by 10 · cited 5×
“sistant to GC-induced apoptosis, suggesting that this mode of cell death is likely to rely on the binding of GR to GREs (197, 320).”
BackgroundInfluentialCalzi, S. L., Periyasamy, S., Li, D.-P., & Sánchez, E. R. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00180-7 · Cited by 10
Emerging mechanisms of the behavioral effects of steroids
Flanagan‐Cato, L. M., & Fluharty, S. J. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80145-6 · Cited by 9
Briggs, W. A., Han, S., Miyakawa, H., Burdick, J. F., & Kwon, H. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007651 · Cited by 9
The Dynamics of Intranuclear Movement and Chromatin Remodeling by the Glucocorticoid Receptor
Hager, G. L. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_8 · Cited by 9
Schmidt, P., Holsboer, F., & Spengler, D. (2001) · Max Planck Institute for Plasma Physics · Cited by 9
Immune Monitoring of Glucocorticoid Therapy
Reinke, P., Bevilacqua, M. P., Tryon, V. V., Cheronis, J. C., & Volk, H. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_2 · Cited by 7 · cited 1×
“Finally, the detection of the activation state of mediators of the NF- B and MAPK pathway could serve as a possible diagnostic tool for early recognition of steroid resistance, thereby protecting patients from the undesired severe side effects of prolonged and ineffective steroid treatment (161, 186, 188).”
BackgroundCytosolic Glucocorticoid Receptor-Interacting Proteins
Wikström, A. C., Widén, C., Erlandsson, A., Hedman, E., & Zilliacus, J. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_11 · Cited by 7
Mast Cells as Targets for Glucocorticoids in the Treatment of Allergic Disorders
Kassel, O., & Cato, A. C. B. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_10 · Cited by 7
The Glucocorticoid Receptor β-Isoform: A Perspective on Its Relevance in Human Health and Disease
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_12 · Cited by 7
New asthma targets: recent clinical and preclinical advances
Greenfeder, S. A., & Anthes, J. C. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00349-6 · Cited by 7 · cited 1×
“GC-responsive tissues with an activated inflammatory response (mediated by activated NF- B) may become resistant to GC signaling because of a blocked GR function (180, 185, 698, 699).”
BackgroundEditorial: The Impact of Genomics and Proteomics on Endocrinology
Thompson, E. B. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.9998 · Cited by 7
A second pathway for modulating glucocorticoid receptor transactivation properties
Chen, S., & Simons, S. S. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00333-7 · Cited by 6
Glucocorticoid-Inducible Genes That Regulate T-Cell Function
Mittelstadt, P. R., Galon, J., Franchimont, D. P., O’Shea, J. J., & Ashwell, J. D. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_18 · Cited by 6
Barnes, P. J. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_1 · Cited by 5 · cited 1×
“Combinations of GCs with MAPK inhibitors or -adrenergic agonists have already proven their therapeutic efficacy in the treatment of inflammatory pathologies (161, 163, 181, 182, 525, 698, 722).”
BackgroundThe Anti-inflammatory Action of Glucocorticoid Hormones
Herrlich, P. A., & Göttlicher, M. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_16 · Cited by 5 · cited 1×
“Because no nGRE could be detected in the majority of inflammatory genes, transcriptional interference was discovered to mostly result from cross-talk between the GR and other transcription factors, such as NF- B or AP-1 (Table 2) (224, 225).”
BackgroundWolpoff, M. H. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02728-2 · Cited by 5
DNA-Dependent Cofactor Selectivity of the Glucocorticoid Receptor
Dostert, A., & Heinzel, T. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_15 · Cited by 4
Kinase targets in inflammation
Scherle, P., & Trzăskos, J. M. (1999) · Emerging Therapeutic Targets · doi:10.1517/14728222.3.1.1 · Cited by 4
Bone Effects of Glucocorticoid Therapy
Väänänen, K., & Härkönen, P. L. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_4 · Cited by 3
NF-κB as an emerging target in atopy
Beyaert, R. (1999) · Emerging Therapeutic Targets · doi:10.1517/14728222.3.2.213 · Cited by 3 · cited 1×
“However, disruption or malfunction of these dynamic interactions may result in a fatal outcome of acute inflammation or may predispose for autoimmunity or atopic reactions (129).”
BackgroundStructural Analysis of the GR Ligand-Binding Domain
Egner, U. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_19 · Cited by 2
Special Problems in Glucocorticoid Treatment in Children
Wahn, U. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_6 · Cited by 1
Research works printed but not linked: 10
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
“Nuclear receptors (NRs) are transcription factors that are typically regulated by the binding of specific ligands, such as glucocorticoids, oestrogen, thyroid hormone and retinoic aci”
BackgroundGene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.